Suchergebnisse - "Lopinavir"

PubPharm (474)

1

Evaluation of the efficacy and safety of oral N-acetylcysteine in patients with COVID-19 receiving the routine antiviral and hydroxychloroquine protocol : A randomized controlled clinical trial

enthalten in: Immunity, inflammation and disease | 2023

von Atefi, N. | Goodarzi, A. | Riahi, T. | +7

2

Twenty-eight-day mortality among patients with severe or critical COVID-19 in Hong Kong during the early stages of the pandemic

enthalten in: Hong Kong medical journal = Xianggang yi xue za zhi | 2023

von Chan, A. | Lung, K. | Yu, J. | +2

3

Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic

enthalten in: Therapie | 2023

von Grandvuillemin, A. | Rocher, F. | Valnet-Rabier, M. | +3

4

Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Abdizadeh, R. | Hadizadeh, F. | Abdizadeh, T.

5

A Comparative Study of Antiretroviral (Lopinavir/Ritonavir) and Remdesivir Used in the Pandemic in Iraq on the Clinical Outcome in Patients with SARS-CoV-2

enthalten in: Archives of Razi Institute | 2023

von Alabdalaali, M. | Hadi, A.

6

Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients : experience from the initial use of lopinavir-ritonavir

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Gonzalez-García, R. | Roma, J. | Rodríguez-García, M. | +17

7

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial

enthalten in: Influenza and other respiratory viruses | 2023

von Alotaibi, F. | Alharbi, N. | Rosen, L. | +25

8

Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Mohsenian Naghani, S. | Jansen, M. | Jaspers, T. | +2

9

Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Skalafouris, C. | Samer, C. | Stirnemann, J. | +6

10

The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modeling

enthalten in: Drug metabolism and personalized therapy | 2023

von Alsmadi, M.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]